共 50 条
- [21] Re: R. Jeffrey Karnes, Voleak Choeurng, Ashley E. Ross, et al. Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features. Eur Urol. In press. https://doi.org/10.1016/j.eururo. 2017.03.036 [J]. EUROPEAN UROLOGY, 2017, 72 (06) : E157 - E157
- [22] Reply to Jerome Verine's Letter to the Editor re: Rodolfo Montironi, Marina Scarpelli, Liang Cheng, et al. Immunoglobulin G4-related Disease in Genitourinary Organs: An Emerging Fibroinflammatory Entity Often Misdiagnosed Preoperatively as Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.11.056 [J]. EUROPEAN UROLOGY, 2013, 64 (03) : E53 - E54
- [23] Reply to Henk G. van der Poel, Tessa Buckle and Renato Valdes Olmos' Letter to the Editor re: Steven Joniau, Laura Van den Bergh, Evelyne Lerut, et al. Mapping of Pelvic Lymph Node Metastases in Prostate Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.06.057 [J]. EUROPEAN UROLOGY, 2013, 63 (02) : E21 - E22
- [24] Re: Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fossa, Kristin Austlid Tasken. Association Between Use of β-Blockers and Prostate Cancer-specific Survival: A Cohort Study of 3561 Prostate Cancer Patients with High-risk or Metastatic Disease. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.01.007. [J]. EUROPEAN UROLOGY, 2013, 64 (04) : E86 - E87
- [25] Reply to Urmila Dhakad and Bhupendra Pal Singh's Letter to the Editor re: Dean A. Tripp, J. Curtis Nickel, Jennifer Wong, et al. Mapping of Pain Phenotypes in Female Patients with Bladder Pain Syndrome/Interstitial Cystitis and Controls. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.05.023 [J]. EUROPEAN UROLOGY, 2012, 62 (04) : E74 - E74
- [26] Re: Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fossa, Kristin Austlid Tasken. Association Between Use of β-Blockers and Prostate Cancer-specific Survival: A Cohort Study of 3561 Prostate Cancer Patients with High-risk or Metastatic Disease. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.01.007 [J]. EUROPEAN UROLOGY, 2013, 64 (01) : E10 - E10
- [27] Re: Johann S. de Bono, Matthew R. Smith, Fred Saad, et al. Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.06.033 [J]. EUROPEAN UROLOGY, 2017, 71 (02) : E55 - E55
- [28] Re: Grant D. Stewart, Fiach C. O'Mahony, Alexander Laird, et al. Carbonic Anhydrase 9 Expression Increases with Vascular Endothelial Growth Factor-Targeted Therapy and Is Predictive of Outcome in Metastatic Clear Cell Renal Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.04.007 [J]. EUROPEAN UROLOGY, 2014, 66 (04) : E69 - E70
- [29] Re: Johann S. de Bono, Matthew R. Smith, Fred Saad, et al. Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.06.033 [J]. EUROPEAN UROLOGY, 2017, 71 (01) : E9 - E10
- [30] Re: Logan G. Briggs, Chanan Reitblat, Paul A. Bain, et al. Prehabilitation Exercise Before Urologic Cancer Surgery: A Systematic and Interdisciplinary Review. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.05.015 Strategies for Effective Prehabilitation in Urologic Cancer [J]. EUROPEAN UROLOGY, 2021, 80 (06) : E139 - E140